Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
1999-2-4
|
pubmed:abstractText |
The synthesis and in vitro optimization of the anti-Helicobacter pylori activity of a novel series of benzyloxyisoquinoline derivatives discovered by a random screening process, are described. FR180102 (7f), having a 3-acetamido-2,6-dichlorobenzyl moiety, was found to have extremely potent activity against H. pylori and no effect against a series of common Gram-positive and Gram-negative bacteria.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1897-902
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9873455-Acetamides,
pubmed-meshheading:9873455-Animals,
pubmed-meshheading:9873455-Anti-Bacterial Agents,
pubmed-meshheading:9873455-Helicobacter pylori,
pubmed-meshheading:9873455-Isoquinolines,
pubmed-meshheading:9873455-Magnetic Resonance Spectroscopy,
pubmed-meshheading:9873455-Mice,
pubmed-meshheading:9873455-Microbial Sensitivity Tests,
pubmed-meshheading:9873455-Structure-Activity Relationship
|
pubmed:year |
1998
|
pubmed:articleTitle |
Discovery of a novel benzyloxyisoquinoline derivative with potent anti-Helicobacter pylori activity.
|
pubmed:affiliation |
Medicinal Chemistry Research Laboratories, Fujisawa Pharmaceutical Co. Ltd., Osaka, Japan.
|
pubmed:publicationType |
Journal Article
|